BREAKING_New Long Term Faricimab Data Boosts Drug’s Profile for nAMD, DME and RVO 02
February 9, 2024

New Long-Term Faricimab Data Boosts Drug’s Profile for nAMD, DME and RVO

A swathe of promising new data for Roche’s (Basel, Switzerland) Vabysmo (faricimab-svoa) at the virtual 21st Annual Angiogenesis, Exudation and…

shutterstock_1616300053
December 7, 2023

Could Eye Drops Replace Injections? Experts provide insights into the prospects and challenges of using eye drops to treat retinal conditions

Highlighting recent studies and positive Phase 3 trial results, experts explored promising developments in retinal eye drops, addressing issues of…

Discover our fascinating content at issuu

explore